303
Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014; 16(3).
304
Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009; 126(1): 51–90
305
Mccarthy H, Skokauskas N, Mulligan A, et al. Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood. JAMA Psychiatry. 2013; 70(12): 1329–37
306
Safer DJ, Krager JM. Treatment of Attention-Deficit Hyperactivity Disorder-Reply. JAMA. 1993; 269(18): 2369
307
Maraini D, Dacia Maraini Intervista Giorgio Antonucci. La Stampa, 26.7., 29 e 30.12.'78
308
Moffitt T, Melchior M. Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? The American Journal of Psychiatry. 2007; 146(6): 856–858. doi: 10.1176/appi.ajp.164.6.856
309
Shaw, P., Malek, M., Watson, B., Greenstein, D., de Rossi, P., & Sharp, W. (2013). Trajectories of Cerebral Cortical Development in Childhood and Adolescence and Adult Attention-Deficit/Hyperactivity Disorder, Biological Psychiatry, 74, 599–606
310
Sripada CS, Kessler D, Angstadt M. Lag in maturation of the brain's intrinsic functional architecture in attention-deficit/hyperactivity disorder. Proc Natl Acad Sci USA. 2014; 111(39): 14259–64
311
Volkow ND, Wang G-J, Newcorn JH, et al. Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway. Molecular psychiatry. 2011;16(11): 1147–1154. doi: 10.1038/mp.2010.97
312
Голдберг Э. Управляющий мозг: Лобные доли, лидерство и цивилизация. – М.: Смысл, 2003
313
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477352/.
314
https://www.frontiersin.org/articles/10.3389/fphys.2020.583005/full.
315
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015
316
https://www.nature.com/articles/s41588–018–0269–7.
317
https://www.nature.com/articles/s41593–019–0527–8.
318
Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry. 2002; 41 (4): 378–85.
319
Hartmann T. Attention Deficit Disorder, A Different Perception. Underwood Books; 1997
320
https://onlinelibrary.wiley.com/doi/abs/10.1002/ajpa.21358.
321
Eisenberg et al., 2008. Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. // BMC Evolutionary Biology, 8.
322
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015
323
Gilman L, Career Advice from the Corner Office: Famous People with ADHD, ADDitude, 2005 Dec-Jan.
324
Адералл – лекарство от СДВГ, схоже с риталином.
325
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015.
326
Holly A. White. Thinking "Outside the Box": Unconstrained Creative Generation in Adults with Attention Deficit Hyperactivity Disorder. The Journal of Creative Behavior, 2018.
327
World Health Organization (2012). Pharmacological and nonpharmacological interventions for children with attention-deficit hyperactivity disorder (ADHD). Geneva: WHO
328
Philipsen A, Richter H, Peters J, et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis. 2007; 195(12): 1013–9.
329
Weiss M, Murray C, Wasdell M, Greenfield B, Giles L, Hechtman L. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry. 2012; 12:30. doi: 10.1186/1471–244X-12–30.
330
Morton WA, Stockton GG. Methylphenidate Abuse and Psychiatric Side Effects. Primary Care Companion to The Journal of Clinical Psychiatry. 2000; 2(5): 159–164.
331
Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the Efficacy of Medications for ADHD Using Meta-analysis. Medscape General Medicine. 2006; 8(4): 4.
332
Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005; 43(7): 831–42
333
Michelson D., Faries D., Wernicke J. et al. Atomoxetine in the treatment of children and adolescents with attention-deficity hyperactivity disorder: a randomised, placebo-controlled, dose-response study // Pediatrics. 2001. № 108. P. 1–9.
334
Tor-Arne Hegvik, Kai Waloen, Sunil K. Pandey, Stephen V. Faraone, Jan Haavik, Tetyana Zayats. Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment. Molecular Psychiatry.
335
Зиновьева А. Космический пришелец по имени Иван // Московский комсомолец. – 2013. – 5 июля (№ 26272).
336
Schechter MD, Timmons GD. Objectively measured hyperactivity – II. Caffeine and amphetamine effects. J Clin Pharmacol. 1985; 25(4): 276–80.
337
Arnold LE, Christopher J, Huestis R, Smeltzer DJ. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. Arch Gen Psychiatry. 1978; 35(4): 463–73.
338
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015
339
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538574/.
340
В этой главе мы решили не писать про аутизм в целом (хотя это, безусловно, интересная и заслуживающая внимания тема),
